MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice

Development of novel more efficient preventive vaccines against tuberculosis (TB) is crucial to achieve TB eradication by 2050, one of the Millennium Development Goals (MDG) for the current century. MTBVAC is the first and only live attenuated vaccine based on a human isolate of Mycobacterium tuberc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Tuberculosis (Edinb)
Autori principali: Aguilo, Nacho, Uranga, Santiago, Marinova, Dessislava, Monzon, Marta, Badiola, Juan, Martin, Carlos
Natura: Artigo
Lingua:Inglês
Pubblicazione: Churchill Livingstone 2016
Soggetti:
Model Systems
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4727503/
https://ncbi.nlm.nih.gov/pubmed/26786657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tube.2015.10.010
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi